Thank you, Madam Chair.
Thank you to all of the witnesses for appearing this Friday for this important discussion on TRIPS.
I think I'll start with you, Mr. Warner.
Before I do, seeing as how the topic of booster shots and possibly other vaccines was raised by Mr. DiCarlo, I thought it important to mention that Canada today reached a deal with Pfizer to secure 35 million booster shots for next year and 30 million in 2023. We also have options for 120 million more doses over the next few years.
Mr. Warner, getting to the crux of the matter on TRIPS, you mentioned being involved in helping a multinational pharma company distribute HIV-AIDS drugs globally. Can you let us know about the technology transfers involved in that process, maybe some of the knowledge sharing that went on there, and how we might learn from that experience in this case?